| dbo:abstract |
PTI-1 (SGT-48) is an indole-based synthetic cannabinoid. It is one of few synthetic cannabinoids containing a thiazole group and is closely related to PTI-2. These compounds may be viewed as simplified analogues of indole-3-heterocycle compounds originally developed by Organon and subsequently further researched by Merck. (en) Le PTI-1 (SGT-48) est un cannabinoïde synthétique à base d'indole. C'est l'un des rares cannabinoïdes synthétiques contenant un groupe thiazole et il est étroitement lié au PTI-2. Ces composés peuvent être considérés comme des analogues simplifiés des composés d'indole-3-hétérocycle initialement développés par Organon BioSciences et ultérieurement étudiés par Merck. (fr) |
| dbo:casNumber |
1400742-46-2 |
| dbo:fdaUniiCode |
FSE9R26430 |
| dbo:thumbnail |
wiki-commons:Special:FilePath/PTI-1_structure.png?width=300 |
| dbo:wikiPageID |
47188729 (xsd:integer) |
| dbo:wikiPageLength |
3024 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1082426145 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbc:Cannabinoids dbc:Designer_drugs dbc:Indoles dbr:Organon_International dbr:Thiazole dbc:Thiazoles dbr:PTI-2 dbc:Diethylamino_compounds dbr:JWH-018 dbr:LBP-1_(drug) dbr:Synthetic_cannabinoid dbr:Indole dbr:Merck_&_Co. |
| dbp:c |
21 (xsd:integer) |
| dbp:casNumber |
1400742 (xsd:integer) |
| dbp:chemspiderid |
32055537 (xsd:integer) |
| dbp:h |
29 (xsd:integer) |
| dbp:iupacName |
N,N-diethyl-N-ethanamine (en) |
| dbp:legalCa |
Schedule II (en) |
| dbp:legalDe |
NpSG (en) |
| dbp:legalUk |
Class B (en) |
| dbp:n |
3 (xsd:integer) |
| dbp:s |
1 (xsd:integer) |
| dbp:smiles |
CCCCCN1C=CC3=CC=CC=C31.Cl (en) |
| dbp:stdinchi |
1 (xsd:integer) |
| dbp:stdinchikey |
NPYOTZAJIONLKZ-UHFFFAOYSA-N (en) |
| dbp:unii |
FSE9R26430 (en) |
| dbp:wikiPageUsesTemplate |
dbt:Cannabinoid-stub dbt:Cannabinoidergics dbt:Cannabinoids dbt:Drugbox dbt:Reflist dbt:Short_description dbt:Fdacite |
| dcterms:subject |
dbc:Cannabinoids dbc:Designer_drugs dbc:Indoles dbc:Thiazoles dbc:Diethylamino_compounds |
| gold:hypernym |
dbr:Cannabinoid |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug |
| rdfs:comment |
PTI-1 (SGT-48) is an indole-based synthetic cannabinoid. It is one of few synthetic cannabinoids containing a thiazole group and is closely related to PTI-2. These compounds may be viewed as simplified analogues of indole-3-heterocycle compounds originally developed by Organon and subsequently further researched by Merck. (en) Le PTI-1 (SGT-48) est un cannabinoïde synthétique à base d'indole. C'est l'un des rares cannabinoïdes synthétiques contenant un groupe thiazole et il est étroitement lié au PTI-2. Ces composés peuvent être considérés comme des analogues simplifiés des composés d'indole-3-hétérocycle initialement développés par Organon BioSciences et ultérieurement étudiés par Merck. (fr) |
| rdfs:label |
PTI-1 (fr) PTI-1 (en) |
| owl:sameAs |
yago-res:PTI-1 wikidata:PTI-1 dbpedia-fr:PTI-1 https://global.dbpedia.org/id/zxVY |
| prov:wasDerivedFrom |
wikipedia-en:PTI-1?oldid=1082426145&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/PTI-1_structure.png |
| foaf:isPrimaryTopicOf |
wikipedia-en:PTI-1 |
| is dbo:wikiPageRedirects of |
dbr:SGT-48 |
| is dbo:wikiPageWikiLink of |
dbr:List_of_designer_drugs dbr:List_of_psychedelic_drugs dbr:BzODZ-EPyr dbr:Eukaryotic_translation_elongation_factor_1_alpha_1 dbr:PTI-2 dbr:LBP-1_(drug) dbr:PTI-3 dbr:SGT-48 |
| is foaf:primaryTopic of |
wikipedia-en:PTI-1 |
